ePrints

A phase I dose-escalation study of AZD3965, an oral monocarboxylate transporter 1 inhibitor, in patients with advanced cancer

Lookup NU author(s): Professor Gareth VealORCiD, Professor Steve WedgeORCiD, Dr Christopher BaconORCiD, Professor Philip Sloan, Professor Alastair GreystokeORCiD, Elizabeth Howell, Dr Will Innes, Dr Chris PlummerORCiD, Dr George Petrides, Professor Ruth PlummerORCiD

Downloads

• Accepted version [.pdf]

Licence

This is the authors' accepted manuscript of an article that has been published in its final definitive form by American Association for Cancer Research, 2023.

For re-use rights please refer to the publisher's terms and conditions.

Publication metadata

Author(s): Halford S, Veal GJ, Wedge SR, Payne GS, Bacon CM, Sloan P, Dragoni I, Heinzmann K, Potter S, Salisbury BM, Chenard-Poirier M, Greystoke A, Howell EC, Innes WA, Morris K, Plummer C, Rata M, Petrides G, Keun HC, Banerji U, Plummer R

Publication type: Article

Publication status: Published

Journal: Clinical Cancer Research

Year: 2023

Volume: 29

Issue: 8

Pages: 1429-1439

Print publication date: 15/04/2023

Online publication date: 18/01/2023

Acceptance date: 13/01/2023

Date deposited: 06/10/2025

ISSN (print): 1078-0432

ISSN (electronic): 1557-3265

Publisher: American Association for Cancer Research

URL: https://doi.org/10.1158/1078-0432.CCR-22-2263

DOI: 10.1158/1078-0432.CCR-22-2263

ePrints DOI: 10.57711/pwp5-3t29

PubMed id: 36652553

Altmetrics

Share